[Secondary amyloidosis associated with overlap syndrome of rheumatoid arthritis, progressive systemic sclerosis and polymyositis]. 1989

I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009220 Myositis Inflammation of a muscle or muscle tissue. Inflammatory Myopathy,Myositis, Focal,Myositis, Infectious,Idiopathic Inflammatory Myopathies,Idiopathic Inflammatory Myopathy,Idiopathic Inflammatory Myositis,Infectious Myositis,Inflammatory Muscle Diseases,Inflammatory Myopathies, Idiopathic,Inflammatory Myopathy, Idiopathic,Muscle Diseases, Inflammatory,Myopathies, Idiopathic Inflammatory,Myopathy, Inflammatory,Myositis, Proliferative,Focal Myositides,Focal Myositis,Infectious Myositides,Inflammatory Muscle Disease,Inflammatory Myopathies,Muscle Disease, Inflammatory,Myopathies, Inflammatory,Myopathy, Idiopathic Inflammatory,Myositides,Myositides, Focal,Myositides, Infectious,Myositides, Proliferative,Proliferative Myositides,Proliferative Myositis
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D004121 Dimethyl Sulfoxide A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. DMSO,Dimethyl Sulphoxide,Dimethylsulfoxide,Dimethylsulphinyl,Dimethylsulphoxide,Dimexide,Rheumabene,Rimso,Rimso 100,Rimso-50,Sclerosol,Sulfinylbis(methane),Rimso 50,Rimso50,Sulfoxide, Dimethyl,Sulphoxide, Dimethyl
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota
September 2003, Rheumatology international,
I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota
July 2006, Rheumatology international,
I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota
August 2018, Clinical rheumatology,
I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota
June 1991, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota
December 1990, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota
September 2012, Journal of gastrointestinal and liver diseases : JGLD,
I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota
July 2007, The Journal of rheumatology,
I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota
October 1988, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota
January 2001, Clinical rheumatology,
I Kumagai, and T Sasaki, and K Takatori, and K Shikata, and S Ikeda, and M Takaoka, and H Makino, and Z Ota
March 1963, Boletin de la Asociacion Medica de Puerto Rico,
Copied contents to your clipboard!